Fangauf, S.V.* ; Herbeck Belnap, B.* ; Meyer, T.* ; Albus, C.* ; Binder, L.* ; Deter, H.C.* ; Ladwig, K.-H. ; Michal, M.* ; Ronel, J.* ; Rothenberger, A.* ; Söllner, W.* ; Wachter, R.* ; Weber, C.S.* ; Herrmann-Lingen, C.*
     
    
        
Associations of NT-proBNP and parameters of mental health in depressed coronary artery disease patients.
    
    
        
    
    
        
        Psychoneuroendocrinology 96, 188-194 (2018)
    
    
 	
    
	
	  DOI
 DOI
	  PMC
 PMC
		
		
			Open Access Green as soon as Postprint is submitted to ZB.
		
     
    
      
      
	
	    Natriuretic peptides (NP) are involved in the regulation of blood pressure and blood volume, and are elevated in patients with coronary artery disease (CAD). They are used as markers for illness severity, but their role in mental health is not well understood. Recently, A-type NP (ANP) has been associated with reduced anxiety in studies on cardiac patients; however, this study is the first to assess this effect for B-type NP (BNP) and for further dimensions of well-being and mental health. Depression, anxiety, and distress are more common in CAD patients than in the general population and are most likely not only influenced by psychological adaptation but also by neurobiological processes. We used baseline N-terminal proBNP (NT-proBNP) samples and psychometric assessments of 529 at least mildly depressed (Hospital Anxiety and Depression Scale, depression score >= 8) CAD patients from the multicenter Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease (SPIRR-CAD) trial. Psychosocial status was assessed using standardized self-rating questionnaires on anxiety, depression, coping with illness, vital exhaustion, type D personality, and quality of life. Separate linear regression models for each psychometric scale revealed significant negative correlations of NT-proBNP with anxiety, depression, vital exhaustion, depressive coping, and negative affectivity. Moreover, patients with higher levels of NT-proBNP experienced less bodily pain and had a better self-rated mental health, despite worse physical functioning. Linear regression adjusted for age, sex, and physical functioning (Short Form Health Survey [SF-36]) revealed NT-proBNP to be a significant predictor for all tested measures of the patients' psychosocial status. These results indicate that NT-proBNP is not only positively associated with greater disease severity in mildly to moderately depressed CAD patients but also with better psychosocial status and mental well-being. Possible mechanisms of this effect are discussed.
	
	
	    
	
       
      
	
	    
		Impact Factor
		Scopus SNIP
		Web of Science
Times Cited
		Scopus
Cited By
		Altmetric
		
	     
	    
	 
       
      
     
    
        Publication type
        Article: Journal article
    
 
    
        Document type
        Scientific Article
    
 
    
        Thesis type
        
    
 
    
        Editors
        
    
    
        Keywords
        Natriuretic Peptide ; Coronary Artery Disease ; Mental Health ; Anxiety ; Depression ; Quality Of Life; Atrial-natriuretic-peptide; Chronic Heart-failure; Stepwise Psychotherapy Intervention; Quality-of-life; Myocardial-infarction; D Personality; Cardiovascular Events; Terminal Fragment; Randomized-trial; Cardiac Events
    
 
    
        Keywords plus
        
    
 
    
    
        Language
        english
    
 
    
        Publication Year
        2018
    
 
    
        Prepublished in Year
        
    
 
    
        HGF-reported in Year
        2018
    
 
    
    
        ISSN (print) / ISBN
        0306-4530
    
 
    
        e-ISSN
        1873-3360
    
 
    
        ISBN
        
    
    
        Book Volume Title
        
    
 
    
        Conference Title
        
    
 
	
        Conference Date
        
    
     
	
        Conference Location
        
    
 
	
        Proceedings Title
        
    
 
     
	
    
        Quellenangaben
        
	    Volume: 96,  
	    Issue: ,  
	    Pages: 188-194 
	    Article Number: ,  
	    Supplement: ,  
	
    
 
    
        
            Series
            
        
 
        
            Publisher
            Elsevier
        
 
        
            Publishing Place
            The Boulevard, Langford Lane, Kidlington, Oxford Ox5 1gb, England
        
 
	
        
            Day of Oral Examination
            0000-00-00
        
 
        
            Advisor
            
        
 
        
            Referee
            
        
 
        
            Examiner
            
        
 
        
            Topic
            
        
 
	
        
            University
            
        
 
        
            University place
            
        
 
        
            Faculty
            
        
 
    
        
            Publication date
            0000-00-00
        
 
         
        
            Application date
            0000-00-00
        
 
        
            Patent owner
            
        
 
        
            Further owners
            
        
 
        
            Application country
            
        
 
        
            Patent priority
            
        
 
    
        Reviewing status
        Peer reviewed
    
 
    
        Institute(s)
        Institute of Epidemiology (EPI)
    
 
    
        POF-Topic(s)
        30202 - Environmental Health
    
 
    
        Research field(s)
        Genetics and Epidemiology
    
 
    
        PSP Element(s)
        G-504000-003
    
 
    
        Grants
        
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2018-07-11